Hainan Haiyao: Intends to reduce its stake in China Antibody by no more than 5%.

Hainan Haiyao announced on April 3 that the company plans to reduce its stake in China Antibody Pharmaceutical Co., Ltd. through centralized bidding and block trading, with the reduction of no more than 68 million shares.